Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : CELSION CORP. (CLN was CELN) UP $.33 TO $.59 ON HUGE NEWS -- Ignore unavailable to you. Want to Upgrade?

To: David Sirk who wrote (199)	2/1/1999 2:47:00 AM
From: Basildon Bond	Respond to of 518

I'm pleased you've made money already, and good luck in the short term. When doing my DD I was concerned to find that the license to use the patent held by MIT cost nothing more than $100,000 or so. Now, we all know that good deals get done every once in a while, but I have to ask myself why MIT would ask such a low price for a patent license, when it could get many times more from one of the established companies in the filed. Put it another way, how many calls would MIT have to make before it grabbed the interest of a major player? I'm sure there's money in this stock in the short term, but long term??????? Why am I interested in this stock? I have a position in NovaMed OTC BB NVMD, which sells non-silicon breast implants outside the USA. Nothing spectacular about it though.